SHORT MINI-FUTURE - MERCK & CO. Stock

Certificat

DE000VD22SR5

Market Closed - Boerse Frankfurt Warrants 13:56:41 2024-05-24 EDT
2.58 EUR +4.45% Intraday chart for SHORT MINI-FUTURE - MERCK & CO.
1 month-9.79%
Date Price Change
24-05-24 2.58 +4.45%
24-05-23 2.47 +1.23%
24-05-22 2.44 -0.81%
24-05-21 2.46 +2.50%
24-05-20 2.4 -2.04%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 01:56 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD22SR
ISINDE000VD22SR5
Date issued 2024-03-28
Strike 157.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.05
Lowest since issue 2.3

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
141.9 USD
Spread / Average Target
+9.57%
Consensus